logo

For the Inventor, By the Inventor

Florsheim am Main, Germany

Max Hropot

This inventor holds 17 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Hoechst Aktiengesellschaft, Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , Aventis Pharma Deutschland, Gmbh. Active years: 1980-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Max Hropot. Retrieved from https://idiyas.com/inventor/max-hropot

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17

% Patents Active = 94.1

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 59(Granted Patents)


Location History:

  • Frankfurt-am-Main, DE (1980)
  • Florsheim am Main, DE (1983 - 1991)
  • Florsheim, DE (1997 - 1999)
  • Flörsheim, DE (2001 - 2002)

Company Filing History:

goldMedal16 out of 6,705 
 
Hoechst Aktiengesellschaft
 patents
silverMedal2 out of 1,335 
 
Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V.
 patents
bronzeMedal1 out of 330 
 
Aventis Pharma Deutschland, Gmbh
 patents
where one patent can have more than one assignee

Years Active: 1980-2002

Loading Chart...
Areas of Expertise:
Bradykinin Antagonists
Sulfonamide Derivatives
Diuretic Peptides
Cinnamic Acid Guanidides
Hirudin Derivatives
Aminoalkanoic Acids
Benzoic Acids
Nitroanthranilic Acids
Salidiuretic Activities
Chromans
Pharmaceuticals
Medicaments
17 patents (USPTO):Explore Patents
1. 6399824 - Substituted cinnamic, acid guanidides, process for their preparation, their use as a medicament, and medicament comprising them (2002-06-04),
2. 6191164 - Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them (2001-02-20),
3. 5863901 - Use of bradykinin antagonists for the production of pharmaceuticals for (1999-01-26),
4. 5786365 - Use of nonpeptide bradykinin antagonists for the treatment and (1998-07-28),
5. 5674838 - Hirudin derivatives and a process for their preparation (1997-10-07),
6. 5011825 - Peptides influencing diuresis and natriuresis, a process for their (1991-04-30),
7. 4994493 - N-substituted 5-nitroanthranilic acids, a process for their preparation, (1991-02-19),
8. 4942176 - N-substituted aminoalkanoic acids, a process for their preparation, (1990-07-17),
9. 4929643 - Benzenesulfonamide derivatives and a process for the preparation thereof (1990-05-29),
10. 4921875 - Use of amino-substituted benzoic acids as remedies for diarrhea, and (1990-05-01),
11. 4849444 - Benzenesulfonamide derivatives and a process for the medical use thereof (1989-07-18),
12. 4766241 - 2-Aminomethyl-6-sulfamoylphenol derivatives with salidiuretic activities (1988-08-23),
13. 4607030 - 2-aminomethyl-6-sulfamoylphenol derivatives, a process for their (1986-08-19),
14. 4574128 - 5-(4-Chloro-3-sulfamoylbenzoyl)-2,3-dihydro-2-benzofurancarboxylic acids (1986-03-04),
15. 4478843 - 5-Phenyltetrazoles and their use as salidiuretics (1984-10-23),

Title: The Innovative Journey of Max Hropot

Introduction: Max Hropot, a visionary inventor hailing from Florsheim am Main, Germany, has made significant contributions to the world of technology and innovation.

Latest Patents: Max Hropot's latest patents focus on renewable energy solutions and sustainable technologies, showcasing his commitment to environmental conservation.

Career Highlights: Throughout his illustrious career, Max Hropot has been recognized for his groundbreaking inventions in the fields of clean energy, robotics, and artificial intelligence. His innovative spirit has led to the development of cutting-edge technologies that have revolutionized various industries.

Collaborations: Max Hropot has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His partnerships have been instrumental in pushing the boundaries of innovation and driving progress in the tech sector.

Conclusion: Max Hropot's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in the global tech community. His contributions continue to inspire future generations of inventors to push the limits of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…